Prof. apt. Auliya A. Suwantika, Ph.D
Vice Dean for Resources and Organization
 |
 |
A. PERSONAL
| Name | : | Prof. apt. Auliya A. Suwantika, Ph.D. |
| Date & place of birth | : | Tegal, 4 February 1983 |
| Affiliation | : | Department of Pharmacology and Clinical Pharmacy, Faculty of Pharmacy, Universitas Padjadjaran |
| Address | : | Jl. Raya Bandung-Sumedang Km. 21 Jatinangor, Sumedang 45363, West Java |
| Email address | : | auliya@unpad.ac.id |
| Position | : | Lecturer/Researcher |
| Expertise | : | Pharmacoeconomics, Health Economics, Health Technology Assessment |
B. Education
| 2000 – 20042004 – 2005 | :: | Bachelor of Pharmacy, Universitas PadjadjaranPharmacist, Universitas Padjadjaran |
| 2005 – 2007 | : | Master of Business Administration, Institut Teknologi Bandung |
| 2011 – 2014 | : | PhD of Pharmacoeconomics, University of Groningen |
C. Organization
| 2005 – now2011 – now | :: | Indonesia Pharmacist AssociationInternational Society for Pharmacoeconomics and Outcome Research |
D. Research & Research Grant (in the last 5 years)
| No. | Title | Year | Research Funder |
| 1 | Wildfires and subjective wellbeing in Indonesia: Quantifying the environmental and health impacts | 2020 | Massachusetts Institute of Technology (MIT)-Indonesia Research Alliance |
| 2 | Economic evaluations of social distancing measures for mitigating COVID-19 pandemic in Indonesia | 2020 | Ministry of Education and Culture |
| 3 | Real world data to analyze the impact of COVID-19 pandemic on the cost-effectiveness of family planning program in Indonesia | 2020 | Ministry of Education and Culture |
| 4 | Budget impact analysis of dengue vaccination | 2020 | Ministry of Education and Culture |
| 5 | Economic evaluations of non-pharmacology interventions for mitigating the COVID-19 pandemic in West Java | 2020 | Universitas Padjadjaran |
| 6 | Potential impact of switch options on Pneumococcal Conjugate Vaccine (PCV) introduction in Indonesia | 2019 | Clinton Health Access Initiative |
| 7 | A comprehensive multi-year plan of immunization | 2019 | WHO Indonesia |
| 8 | Growing Indonesia, a Triangular Approach | 2018 – 2020 | European Union |
| 9 | Cost-effectiveness of pneumococcal vaccination in Indonesia | 2018 | Clinton Health Access Initiative |
| 10 | Roadmap of new vaccine introduction | 2018 | Clinton Health Access Initiative |
| 11 | Case report form for chronic heart disease | 2018 | Ministry of Health |
| 12 | Cost-effectiveness of dengue vaccination in West Java | 2017-2020 | Ministry of Research, Technology and Higher Education |
| 13 | Economic evaluations on the use of contraception in primary healthcare centers | 2017 | National Population and Family Planning Board |
| 14 | Cost-effectiveness analysis of referral program in hypertension patients | 2016 | BPJS Kesehatan |
| 15 | Economic impact of dengue vaccination in Indonesia | 2016 | Sanofi Pasteur |
| 16 | Public acceptance of dengue Vaccine | 2016 | AMP Vaccinology |
| 17 | Cost-effectiveness analysis of chronic disease management in hypertension patients | 2015 | BPJS Kesehatan |
| 18 | Customer satisfaction analysis of chronic disease management in primary healthcare centers | 2015 | BPJS Kesehatan |
| 19 | Drug information system for primary healthcare centers | 2015 | Universitas Padjadjaran |
| 20 | Understanding and Utilization of ICD-10 Coding System in Outpatient Setting in Indonesia | 2014 | WHO |
E. Community Service
| No. | Title | Year | Place | IDR |
| 1 | Analysis of e-prescribing in primary healthcare centers | 2016 | Bandung | IDR 10.000.000 |
| 2 | Health education on stunting | 2017 | Karawang | IDR 20.000.000 |
| 3 | Knowledge, attitude and practice toward tuberculosis diseases | 2018 | Karawang | IDR 20.000.000 |
| 4 | Risk factors of cervical cancer | 2019 | Bandung | IDR 15.000.000 |
| 5 | The importance of immunization during the pandemic | 2020 | Bandung | IDR 15.000.000 |
F. Publications in the last 5 years (H-index Scopus: 6, Google: 7)
International Journal
| No | Tittle | Journal | Year | Quartiles | |||
| Q1 | Q2 | Q3 | Q4 | ||||
| 1 | Sustainable Financing for New Vaccines in Indonesia: Challenges and Strategies. | Sustainability | 2020 | √ | |||
| 2 | How can we evaluate the potential of innovative vaccine products and technologies in resource constrained settings? A total systems effectiveness (TSE) approach to decision-making | Vaccine: X | 2020 | √ | |||
| 3 | The Role of Administrative and Secondary Data in Estimating the Costs and Effects of School and Workplace Closures Due to the COVID-19 Pandemic | Data | 2020 | √ | |||
| 4 | Cost-Effectiveness Analysis of Spending on Research and Development to Address the Needs for Innovative Therapeutic Products in Indonesia | Therapeutics and Clinical Risk Management | 2020 | √ | |||
| 5 | Cost-effectiveness of dengue vaccination in Indonesia: Considering integrated programs with Wolbachia-infected mosquitos and health education | International Journal of Environmental Research and Public Health | 2020 | √ | |||
| 6 | Impact of Switch Options on the Economics of Pneumococcal Conjugate Vaccine (PCV) Introduction in Indonesia | Vaccines | 2020 | √ | |||
| 7 | Potential impacts of a COVID-19 pandemic on the immunization performance in Indonesia | Expert Review of Vaccines | 2020 | √ | |||
| 8 | Real-world data for health technology assessment for reimbursement decisions in Asia: Current landscape and a way forward | International Journal of Technology Assessment in Health Care | 2020 | √ | |||
| 9 | Pneumococcal vaccination for children in Asian countries: A systematic review of economic evaluation studies | Vaccines | 2020 | √ | |||
| 10 | Knowledge, acceptance and willingness to pay for Dengue vaccine in Yogyakarta and Jakarta | Epidemiology Biostatistics and Public Health | 2020 | √ | |||
| 11 | Measurement of the quality of life of Prolanis hypertension patients in sixteen primary healthcare centers in Pandeglang District, Banten Province, Indonesia, using EQ-5D-5L instrument | Patient Preference and Adherence | 2020 | √ | |||
| 12 | The challenges in eradication of iron deficiency anemia in developing countries | Systematic Reviews in Pharmacy | 2020 | √ | |||
| 13 | Effect of anti-hypertension counselling training on increased pharmacist knowledge in public health centers in Pandeglang Regency | Journal of Global Pharma Technology | 2020 | √ | |||
| 14 | Cost of Illness Study of Patients with Dengue Hemorrhagic Fever at One of the Private Hospitals in Yogyakarta Society | Journal of Pharmacy and Bioallied Sciences | 2019 | √ | |||
| 15 | Cost-effectiveness of standardized-herbal medicine for DHF inpatients in a primary health center | Journal of Advanced Pharmacy Education and Research | 2019 | √ | |||
| 16 | Knowledge, attitudes, and practices of lung cancer risk factors in West Bandung Society | Journal of Pharmacy and Bioallied Sciences | 2019 | √ | |||
| 17 | Economic Evaluations of Dengue Vaccination in Southeast Asia Region: Evidence from A Systematic Review | Value in Health Regional Issues | 2019 | √ | |||
| 18 | Risk factors of lung cancer in Indonesia: A qualitative study | Journal of Advanced Pharmacy Education and Research | 2019 | √ | |||
| 19 | An economic evaluation of diabetes mellitus management in South East Asia | Journal of Advanced Pharmacy Education and Research | 2019 | √ | |||
| 20 | Utilization and cost minimization study of antihypertensive drugs in primary healthcare center | Journal of Advanced Pharmacy Education and Research | 2019 | √ | |||
| 21 | Correlation of rainfall and socio-economic with incidence dengue in Jakarta, Indonesia | Journal of Advanced Pharmacy Education and Research | 2019 | √ | |||
| 22 | Cost-effectiveness analysis of psychotropic therapy in adolescent patients with intellectual disability in Mental Hospital of West Java Provincial State 2015-2017 | Journal of Advanced Pharmacy Education and Research | 2019 | √ | |||
| 23 | Incidence, causative drugs, and economic consequences of drug-induced SJS, TEN, and SJS- TEN overlap and potential drug–drug interactions during treatment: A retrospective analysis at an Indonesian referral hospital | Therapeutics and Clinical Risk Management | 2017 | √ | |||
| 24 | Satisfaction Level of Patients, Physicians and Private Primary Healthcare Center Managers with Chronic Disease Management Program in Indonesia | Asian Journal of Pharmaceutical and Clinical Research | 2017 | √ | |||
| 25 | Cost-effectiveness Analysis of Ceftazidime- Levofloxacin and Cefotaxime-Erythromycin as Empirical Antibiotic Combinations in Respiratory Infection-induced Sepsis | Asian Journal of Pharmaceutical and Clinical Research | 2017 | √ | |||
| 26 | Cost-Utility Analysis of Human Papillomavirus Vaccination and Cervical Screening on Cervical Cancer Patient in Indonesia | Value in Health Regional Issues | 2016 | √ | |||
| 27 | The cost-effectiveness of HPV vaccination in addition to screening: a Dutch perspective | Expert Review of Vaccines | 2015 | √ | |||
| 28 | Expanding access to non-traditional vaccines: a perspective from Indonesia | Expert Review of Vaccines | 2014 | √ | |||
| 29 | Cost effectiveness of hepatitis A vaccination in Indonesia | Human Vaccines and Immunotherapeutics | 2014 | √ | |||
| 30 | Accelerating the introduction of rotavirus immunization in Indonesia | Expert Review of Vaccines | 2014 | √ | |||
| 31 | Economic evaluations of hepatitis A vaccination in middle-income countries | Expert Review of Vaccines | 2013 | √ | |||
| 32 | Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia | BMC Public Health | 2013 | √ | |||
| 33 | Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account | Vaccine | 2013 | √ |
National Accreditation Journal
| No | Tittle | Journal | Year | Sinta | ||
| S1-S2 | S3-S4 | S5-S5 | ||||
| 1 | Efek toksik merkuri dalam krim pencerah wajah dari perspektif klinis | Indonesian Journal of Clinical Pharmacy | 2020 | √ | ||
| 2 | Profil penatalaksanaan kanker serviks stadium IIB-IIIB dengan terapi radiasi dan kemoradiasi di RSUP Dr. Hasan Sadikin Bandung periode tahun 2015-2017 | Indonesian Journal of Clinical Pharmacy | 2019 | √ | ||
| 3 | Analisis efektivitas biaya penggunaan antibiotik pada pasien community-acquired pneumonia di RSUP Dr. Hasan Sadikin Bandun | Indonesian Journal of Clinical Pharmacy | 2019 | √ | ||
| 4 | Analisis efektivitas biaya penggunaan kontrasepsi di Indonesia tahun 2014-2017 | Indonesian Journal of Clinical Pharmacy | 2019 | √ | ||
| 5 | Analisis minimalisasi biaya penggunaan psikotropika pada pasien remaja dengan disabilitas intelektual di RSJ Provinsi Jawa Barat tahun 2015-2017 | Indonesian Journal of Clinical Pharmacy | 2018 | √ | ||
| 6 | Analisis tingkat kepuasam pasien rawat inap DM Tipe 2 dengan komplikasi ginjal di fasilitas kesehatan tingkat lanjut | Indonesian Journal of Clinical Pharmacy | 2018 | √ | ||
| 7 | Analisis efektivitas biaya pengobatan DBD pada pasien BPJS rawat inap di RSUD dr. Adjidarmo Kabupaten Lebak tahun 2014-2015 | Indonesian Journal of Clinical Pharmacy | 2016 | √ | ||
| 8 | Penggunaan suplemen herbal sebagai upaya swamedikasi di Kota Bandung | Indonesian Journal of Clinical Pharmacy | 2015 | √ |
G. SCIENTIFIC MEETINGS AS A SPEAKER IN THE LAST 5 YEARS
| No | Seminar/Symposium | Place | Year | Position | ||
| Plenary/Invited | Oral | Poster | ||||
| 1 | Merck Sharp Dohme (MSD) Webinar Series: Mathematical modelling to estimate the cost-effectiveness of pharmacology and non-pharmacology interventions for mitigating the COVID-19 pandemic. | Virtual | 2020 | √ | ||
| 2 | Indonesian Pharmacist Association Webinar Series: The potential impact of COVID-19 pandemic on the immunization performance in Indonesia | Virtual | 2020 | √ | ||
| 3 | Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Webinar Series: Harm reduction concept for alternative tobacco products in Indonesia. | Virtual | 2020 | √ | ||
| 4 | The 6th International Conference on Pharmacy and Advanced Pharmaceutical Sciences (ICPAPS): Cost-effectiveness of dengue vaccination in Indonesia. | Yogyakarta | 2019 | √ | ||
| 5 | International Health Economics Association (IHEA) 2019 World Congress: Cost-effectiveness and budget impact analyses of PCV introduction in Indonesia | Basel, Switzerland | 2019 | √ | ||
| 6 | Faculty of Pharmacy, Universitas Gadjah Mada, Workshop on Health Technology Assessment. | Yogyakarta | 2017 | √ | ||
| 7 | 2nd Indonesian Conference on Clinical Pharmacy: Modeling for pharmacoeconomics study. | Denpasar, Bali | 2016 | √ | ||
| 8 | 10th Vaccine Congress: Economic evaluation of dengue vaccine in Asia. | Amsterdam, Netherlands | 2016 | √ | ||
| 9 | 3rd InaHEA Congress: Mathematical modeling for cost- effectiveness of vaccination in Indonesia. | Yogyakarta | 2016 | √ | ||
| 10 | ISPOR Indonesia Chapter Conference: Effect of water and sanitation improvements on cost-effectiveness of hepatitis A immunization in Indonesia. | Jakarta | 2016 | √ | ||
| 11 | 9th Vaccine Congress: Effect of breastfeeding interventions on cost- effectiveness of rotavirus immunization in Indonesia. | Seoul, South Korea | 2015 | √ | ||
| 12 | Research Institute of Science in Healthy Aging and Healthcare (SHARE) Conference: Accelerating the introduction of rotavirus immunization in Indonesia | Groningen, Netherlands | 2014 | √ | ||
| 13 | The Economics of Disease Conference: Effect of breastfeeding promotion interventions on cost-effectiveness of rotavirus immunization in Indonesia. | Darmstadt, Germany | 2013 | √ |
H. REVIEWER/EDITOR
| a. Scientific Journal | ||
| No | Position and Journal | Year |
| 1 | Editor: Indonesian Journal of Clinical Pharmacy | 2018 – now |
| 2 | Editor: Asian Journal of Pharmacoepidemiology and Pharmacoeconomics | 2019 – now |
| 3 | Reviewer: BMC Public Health | 2018 – now |
| 4 | Reviewer: Value in Health | 2018 – now |
| 5 | Reviewer: Value in Health Regional Issues | 2018 – now |
| 6 | Reviewer: Infectious Diseases and Therapy | 2018 – now |
| 7 | Reviewer: PLoS One | 2019 – now |
| 8 | Reviewer: BMJ Open | 2020 – now |
| 9 | Reviewer: Patient Preference and Adherence | 2020 – now |
| 10 | Reviewer: Journal of Multidisciplinary Healthcare | 2020 – now |
| 11 | Reviewer: Pediatric Health, Medicine and Therapeutics | 2020 – now |
| 12 | Reviewer: Postgraduate Medicine | 2020 – now |
| b. Research Proposal | ||
| No | Organization | Year |
| 1 | Unpad | 2019 – now |
I. PATENT
| No. | Title | No Patent | Years |
| 1. | |||
| 2. |
J. BOOK & TEACHING MATERIALS IN THE LAST 5 YEARS
| No | Tittles | Press | ISBN | Year |
| 1 | Farmakoekonomi Modeling | UMP Press | 978-602-6697-14-1 | 2018 |
| 2 | Health Priority | USAID | 2020 |
Other Members
Prof. Dr. apt. Anas Subarnas, M.Sc
Chairman of the Faculty Senate
Prof. Dr. apt. Ajeng Diantini, M.Si
Dean Faculty of Pharmacy
apt. Dika Pramita Destiani, M.Farm
Head of Clinical Pharmacy Laboratory
apt. Gofarana Wilar, M.Si., Ph.D
Head of Pharmacology Laboratory
apt. Ivan Surya Pradipta, Ph.D
Research, Innovation and Partnerships Manager
Dr. apt. Aliya Nur Hasanah, M.Si
Vice Dean for Learning, Student Affairs and Research
apt. Neily Zakiyah, M.Sc., Ph.D
Head of Pharmaceutical Service Innovations Study Center
